R.B. Berryman

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation

Ajay K. Gopal, Radhakrishnan Ramchandren, Owen A. O’Connor et al. · Blood · 2012 · 161 citations · Full text

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program

Paul Shaughnessy, Joseph P. Uberti, Steven M. Devine et al. · Bone Marrow Transplantation · 2012 · 35 citations

Hematological Malignancy, Cell Therapy, Medicine +12

Report of a Phase II Study of Clofarabine and Cytarabine in De Novo and Relapsed and Refractory AML Patients and in Selected Elderly Patients at High Risk for Anthracycline Toxicity

Edward Agura, Barry Cooper, Houston Holmes et al. · The Oncologist · 2011 · 30 citations · Full text

SCREENING FOR SUBCLINICAL OSTEOMALACIA IN THE ELDERLY: NORMAL RANGES OR PRAGMATISM?

D. J. Hosking, John Kemm, Megan Knight et al. · The Lancet · 1983 · 19 citations

Bone Disease, Osteopathy, Geriatrics +7